Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:33:42.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:22:18.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:23:10.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous detailed study content with an access-restricted view. This reflects an access issue rather than a modification to the study data.
    Difference
    18%
    Check dated 2026-09-19T20:33:33.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The site revision was updated from v3.6.5 to v3.6.6, indicating a software version bump. This likely reflects an internal update rather than a change to the study information shown on the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:46:22.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing Revision: v3.6.4, indicating an updated version of the page. It reflects an internal update rather than a change to the study content or results.
    Difference
    0.1%
    Check dated 2026-08-08T18:14:19.000Z thumbnail image

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.